Left Menu
Development News Edition

Japan approves dexamethasone as coronavirus treatment

The full results of the large randomised clinical trial released last Friday in the New England Journal of Medicine confirmed the benefits for people with advanced or moderate disease.

Reuters | Updated: 22-07-2020 06:36 IST | Created: 22-07-2020 06:36 IST
Japan approves dexamethasone as coronavirus treatment

Japan's health ministry has approved dexamethasone, a cheap and widely used steroid, as a second treatment of COVID-19 after a trial in Britain showed the drug reduced death rates in hospitalised patients.

The ministry included dexamethasone as an option for treatment along with Gilead Sciences Inc's antiviral drug remdesivir in a recent revision to its handbook. The revision was widely reported by Japanese media on Wednesday and was viewed by Reuters. Shares of Nichi-Iko Pharmaceutical Co, among those that produce the drug, gained as much as 6.5% in early trade.

In results announced last month, a trial by researchers in the United Kingdom showed dexamethasone as the first drug to save lives of COVID-19 patients in what scientists said was a major breakthrough in the coronavirus pandemic. The full results of the large randomised clinical trial released last Friday in the New England Journal of Medicine confirmed the benefits for people with advanced or moderate disease.


TRENDING

OPINION / BLOG / INTERVIEW

Post-COVID-19 Nigeria needs a robust Health Management Information System to handle high disease burden

Nigeria is among a few countries that conceptualised a health management information system HMIS in the early 90s but implementation has been a challenge till date. Besides COVID-19, the country has a huge burden of communicable and non-com...

Morocco COVID-19 response: A fragile health system and the deteriorating situation

Learning from its European neighbors, Morocco imposed drastic measures from the initial stages of the COVID-19 outbreak to try to contain its spread. The strategy worked for a few months but the cases have surged after mid-June. In this sit...

COVID-19: Argentina’s health system inefficiencies exaggerate flaws of health information system

You can recover from a drop in the GDP, but you cant recover from death, was the straightforward mindset of Argentinas President Alberto Fernndez and defined the countrys response to COVID-19. The South American nation imposed a strict...

Rwanda’s COVID-19 response commendable but health information system needs improvement

Rwanda is consistently working to improve its health information system from many years. However, it is primarily dependent on the collection and reporting of health data on a monthly basis. Besides, evaluation studies on Rwandas HIS publis...

Videos

Latest News

Seoul schools resume in-person classes as S.Korea coronavirus cases dip

Schools in the South Korean capital Seoul and nearby areas resumed in-person classes for the first time in almost a month on Monday after daily coronavirus cases dropped to the lowest levels since mid-August.Students returned to schools und...

EXPLAINER-Why is Taiwan-China tension rising and what are the risks?

China sent numerous aircraft close to Taiwan during two days of drills from Friday, causing the islands air force to scramble, as Beijing expressed anger at the visit of a senior U.S. official to Taipei. WHY IS TENSION RISING NOWChina claim...

Coronavirus: 5 players ruled out of French Open qualifying

Two players in the qualifying rounds for the French Open have tested positive for the coronavirus, the French Tennis Federation said, while three others have been in close contact with a coach who also tested positive. The FFT said on Sunda...

India, China to hold sixth Corps Commander-level talks today; MEA to be part of meet: Sources

India and China are scheduled to hold their sixth Corps Commander-level talks on Monday at the Chinese side of the ChushulMoldo meeting point in the Eastern Ladakh sector to address the ongoing military standoff there. According to sources,...

Give Feedback